Project Grant R01HL187199
Award Date 7/21/26
Completion Date 5/31/31
Dollars Obligated $1.2M
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Davis, CA, USA
Similar Awards
- This federal Project Grant award, totaling $1,163,420.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program to the University of California, Davis. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research aims to investigate functional and phenotypic metabolic transitions governing disease state in clear cell renal cell...
- The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded the University of California, Davis $1.624736 million under the Biomedical Research and Research Training program (CFDA 93.859) on August 1, 2026. The award funds research into morphological reprogramming of the endoplasmic reticulum by cellular mucins. The project tests the hypothesis that transmembrane mucins act as membrane curvature generators on the luminal face of the endoplasmic...
- The National Institute of Child Health and Human Development awarded the University of California, Davis $702,556 on May 15, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.865) to model neurodevelopmental risk of imbalanced micronutrient supply in cerebral organoids. The research addresses a gap in understanding potentially detrimental effects of high folic acid (FA) intake on fetal neurodevelopment. While FDA-mandated grain fortification with FA...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of California, Davis $739,895 on September 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to investigate neonatal development of the microbiota-gut-brain axis. The research addresses how bacterial colonization of the gastrointestinal tract, formation of the GI mucosal barrier, and neurogenesis during early life establish a critical developmental...
- The National Heart, Lung, and Blood Institute awarded the University of California Irvine $235,500 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate cardiac complications of dystrophin deficiency in female carriers of Duchenne muscular dystrophy. The research will examine how mosaic expression of dystrophin affects cardiomyocytes differentiated from human induced pluripotent stem cells of female carriers. The work will compare functional...
- The National Heart, Lung, and Blood Institute of the Department of Health and Human Services awarded Duke University $1,532,545 on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to analyze the effect of income-based health insurance benefit designs on cardiovascular disease outcomes and disparities among low-income workers. The research examines whether employers' selective provision of more generous health benefits—such as free cardioprotective medicines or low...
- The National Institutes of Health's National Heart, Lung and Blood Institute awarded $2,350,623 under the Cardiovascular Diseases Research program (CFDA 93.837) to the Regents of the University of Minnesota on May 1, 2021 for a project concluding on April 30, 2022. The project aims to reduce childhood obesity through an individual randomized controlled trial testing combinations of ecological momentary intervention, home visiting, and video feedback delivered to 510 low-income, racially...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded University of California, Davis $151,448 on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and pilot-test implementation strategies and a patient-centered virtual intervention improving transitions from pediatric to adult care for adolescents and young adults with type 1 diabetes. The research comprises three specific aims: developing...
- The National Institute of General Medical Sciences awarded the University of California, Davis $391,526 on May 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for detecting and interpreting structural variants in complex genomic regions and their contribution to complex diseases including neurodevelopmental disorders and cancers. The research addresses gaps in current large-scale genomic studies by focusing on structural...
- The National Institute of Child Health and Human Development awarded the University of California, San Diego $711,432 on May 15, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to fund research on the molecular mechanisms of human meningomyelocele (spina bifida). The award supports recruitment and genetic analysis of family trios with narrowly defined inclusion and exclusion criteria, stratified by prenatal folic acid exposure, to investigate de...